🇺🇸

Index Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — October 26, 2026

The 14 filings for the USA S&P 500 Consumer Staples stream, all dated 2026-10-26, are dominated by Form 4 insider activity rather than financial-statement disclosures, so period-over-period revenue, margin, guidance and capital allocation data are largely absent from this batch. The most material development is a Dollar General 8-K disclosing an FTC and multi-state lawsuit filed October 26, 2026 (following a September 23 draft complaint and settlement order demand), which carries potential material adverse effects on consolidated financials. Procter & Gamble shows the clearest insider selling pattern: CEO Shailesh Jejurikar sold 35,000 shares at $163.09 (~$5.71M) after exercising an equal number of options struck at $78.52, while the Chief Human Resources Officer sold 4,181 shares at $160.71 (~$672K) and a Health Care Group executive sold 4,331 shares at $161.27 (~$698K). Hershey insiders via the Hershey Trust sold shares under a Rule 10b5-1 plan across 14 transactions (~$952K headline value), a pattern consistent with scheduled diversification rather than a conviction signal. Costco filings are almost entirely routine director equity awards (266 shares each) and executive tax withholdings at $1,018.21 per share, which are neutral administrative events. Overall, the batch signals negative insider sentiment at P&G and legal/regulatory risk at Dollar General, with no guidance, dividend or buyback changes disclosed in these filings.

13 high priority 1 medium 14 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 26, 2026

This digest covers three SEC filings from the S&P 500 Industrials intelligence stream dated 2026-10-26: one FedEx 8-K on a CFO appointment and two Norfolk Southern Form 4 insider filings. None of the filings contains period-over-period financial performance data, forward-looking guidance, capital allocation changes, or M&A terms, so the enriched comparison fields are largely empty and conclusions must be drawn from governance and insider signals rather than financial trends. The most material development is FedEx's leadership transition, with Jamere Jackson, former AutoZone CFO, set to become EVP and CFO on November 30, 2026 after a five-month interim period under Claude Russ. At Norfolk Southern, two senior executives recorded routine equity vesting and tax-withholding transactions at $332.09 per share, with no evidence of open-market selling or buying. Overall, the signals in this batch are neutral, with the main actionable item being the FedEx CFO handover ahead of the effective date.

3 high priority 3 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 26, 2026

The Dow Jones 30 stream for 2026-10-26 contains five filings, but the enriched data is thin and largely non-comparable: four of five are Form 4 insider-trade notices and one is a 13F-HR from J&J's venture arm (JJDC). No period-over-period financial comparisons, forward guidance, capital allocation changes, M&A terms, or scheduled-event data were supplied for any filing, so portfolio-level growth or margin trend analysis cannot be performed. The dominant theme is insider selling at Procter & Gamble, where three officers (including Chairman/CEO Shailesh Jejurikar) sold roughly $6.4M combined around $160-163 per share, with the CEO's sale preceded by an option exercise at $78.52 that signals a pattern of exercise-and-sell rather than an outright bearish exit. Goldman Sachs' CAO sold a small amount (~$223K combined), which is low materiality. J&J's 13F shows a concentrated early-stage biotech/medtech book led by Protagonist Therapeutics, but it provides no quarter-over-quarter comparison to judge conviction changes. Overall, the signal set is insider-activity driven and should be treated as low-conviction until financial and guidance data are available.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 26, 2026

Both filings relate to AutoZone Inc., an S&P 500 Consumer Discretionary constituent in the automotive retail group, so the digest is a single-company view rather than a cross-company comparison. The fiscal 2026 10-K shows solid top-line momentum, with net sales up 7.4% to about $20.34B, net income up 3.0%, and diluted EPS up 5.3% to $152.55, supported by 3.3% domestic comparable store sales growth and 374 net new stores. However, the headline 13.5% international comparable sales growth is largely a currency effect, as constant-currency growth slowed to 2.2% from 9.3% in FY2025. Capital structure is more aggressive: total debt rose about $278M to $9.08B while $2.03B of buybacks exceeded free cash flow after capital needs, and adjusted after-tax ROIC fell for a second consecutive year to 35.8%. The 8-K announcing CFO Jamere Jackson's departure on November 25, 2026 for FedEx is a governance event that introduces transition risk, though management characterized the strategy as well established. Net, the filings point to a mature compounder whose returns and leverage profile are becoming the central debate.

2 high priority 2 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 26, 2026

This Healthcare stream digest covers five SEC filings dated October 26, 2026, dominated by insider-selling disclosures from Intuitive Surgical (four Form 4 filings: a director, an SVP-HR, a VP Corporate Controller, and a director) plus one Johnson & Johnson venture-arm 13F-HR. Insider activity is uniformly negative in direction but almost entirely executed under Rule 10b5-1 plans, which substantially dilutes its signal value; the aggregate of roughly $11.9M in disclosed sales across the Intuitive filings (Guthart ~$9.08M, Widman ~$1.83M, Barratt ~$510K, Wadors ~$478K) reflects routine diversification and option-exercise activity rather than an obvious change in management conviction. The filings provide no period-over-period financial metrics, guidance, capital allocation, or M&A data, so trend analysis is limited to insider transaction patterns. The JJDC 13F shows a concentrated early-stage biotech/medtech book, with Protagonist Therapeutics the dominant reported value (~$345.07M) and several tiny positions indicating portfolio-tail housekeeping. Taken together, the day's news is primarily about concentrated insider liquidity at a single large-cap medtech name and modest portfolio disclosures from a strategic investor, with no clear sector-wide directional catalyst. Materiality is moderate across the set, and most actionable follow-up lies in tracking Intuitive's next scheduled disclosures rather than acting on this day's filings alone.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 23, 2026

Six SEC filings from the S&P 500 Technology stream were reviewed for the 2026-10-23 window: five newly published (Marvell 8-K, Salesforce Form 4, two Intuit Form 4s, CrowdStrike Form 4) and one prior-covered context filing (Texas Instruments 10-Q). The dominant data point is Texas Instruments' Q3 2026 print: revenue of $6,055M (+27.7% YoY), net income of $2,425M (+77.8% YoY), and diluted EPS of $2.62 versus $1.48, with Analog (+31.7%) and Embedded Processing (+21.0%) leading growth while the Other segment declined 5.9%. Cash generation strengthened, with nine-month operating cash flow up 56.0% to $7,642M and capex down 54.4% to $1,653M, though the nine-month tax provision rose to $807M from $500M and the company received $1,104M in CHIPS Act proceeds. Marvell's upsized $3B revolver (with a $2B accordion) is a routine liquidity action with no drawn balance, signaling balance-sheet flexibility rather than stress. Insider activity was modest and mostly routine: Intuit directors and Salesforce's co-founder reported equity vesting and tax withholding, while CrowdStrike's CEO sold ~$716K under a Rule 10b5-1 plan. Portfolio-level, the filings point to strong semiconductor cash conversion and sell-side-relevant revenue momentum, with insider selling concentrated in software names. Note that the Form 4 filings provide limited enriched period comparisons and forward-looking data, so the analysis weights the TXN 10-Q most heavily.

6 high priority 6 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 23, 2026

This digest covers four filings dated 2026-10-23 from the NASDAQ-100 stream: two insider Form 4 notices at Intuit, a Form 4 sale by PepsiCo's Chairman and CEO, and Texas Instruments' Q3 2026 10-Q. The standout data point is Texas Instruments, where revenue rose 27.7% YoY to $6,055 million, net income rose 77.8% to $2,425 million, and diluted EPS reached $2.62 versus $1.48, with Analog (+31.7%) and Embedded Processing (+21.0%) leading. Nine-month operating cash flow grew 56.0% to $7,642 million while capex fell 54.4% to $1,653 million, though the 10-Q flags a higher tax provision ($807 million vs $500 million) and a CHIPS Act inflow of $1,104 million that flatters investing cash flow, so the quality of that earnings lift needs scrutiny. The insider activity is small and largely routine: Intuit directors Dalzell and Szkutak converted RSUs at $590.80 (about $30.7K and $25.4K), a neutral signal of compensation-driven ownership, while PepsiCo's CEO sold 30,000 shares at $135.13 (about $4.05M), leaving 491,645 shares held, which is the only transaction in the set that carries a directional concern. No forward-looking guidance, M&A terms, or capital-return changes were included in these filings, so the catalyst view rests mainly on the TI results and the insider-sale read-through.

4 high priority 4 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 23, 2026

Across the 16 filings, the dominant theme is strong reported earnings momentum at American Express and CME Group, tempered by quality-of-earnings questions: AmEx's 31% diluted EPS jump was flattered by a $982M GBTG gain and a tax rate drop to 18.1% from 24.1%, while CME's Q3 revenue rose 13.0% YoY but investment income fell 8.4% and cash roughly halved QoQ-to-year-end. Insider activity was heavily one-directional: Travelers executives (Schnitzer, Toczydlowski, Rowland, Klenk) sold or withheld stock at prices near $400-$406 after option exercises, with Schnitzer's roughly $83M tax withholding the single largest transaction in the set, while Robinhood's director sales ran under a 10b5-1 plan. Capital-markets activity was active: Bank of America created a $2.0B 7.200% preferred series (Series WW), PNC placed $1.5B of senior notes, and S&P Global completed the Mobility separation effective July 1, 2026, with financial detail deferred to Exhibit 99. Balance sheet strength was visible at AmEx (CET1 10.9% vs 10.5% a year earlier) and CME returned $3.6B in dividends and $1.8B in buybacks year-to-date, though its equity fell 7.5% since year-end. Filings with the least analytical content (13G/A, Form 4 awards) were routine and carry low signal value.

12 high priority 4 medium 16 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 23, 2026

Across the four energy filings dated 2026-10-23, the dominant theme is divergence between headline growth and underlying segment profitability. SLB posted Q3 revenue of $9.45B (+6% YoY) but adjusted EBITDA was flat YoY and adjusted EBITDA margin compressed 121 bps to 21.9%, with Well Construction and Reservoir Performance margins falling 266 bps and 223 bps respectively; its $3.4B Kelvion acquisition plus $0.7B assumed debt is the most material capital deployment event. Kinder Morgan showed 9.3% revenue growth and 21.7% net income growth YoY for Q3, but O&M expense rose 20.7% and cash after capex and dividends remains tight, while long-term debt rose to $31.3B. Halliburton's net income swung to $417M from $18M, largely on lower severance ($107M vs $169M in Q3 2025), yet Completion and Production revenue fell 4.2% and that segment's operating income fell 11.1%. Texas Pacific Land's DEFA14A is administrative and carries no financial read-through. The sector pattern is that cost and one-off normalization is flattering reported earnings while core service-line margins are under pressure, making quality of earnings the key diligence question.

2 high priority 2 medium 4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 23, 2026

Four filings were reviewed for the USA S&P 500 Consumer Staples stream dated 2026-10-23, of which three are in scope. Philip Morris International's nine-month 2026 data show top-line strength (net revenues up 8.2% to $32,776 million, operating income up 15.4%) undermined at the bottom line by a $511 million RBH impairment and a $330 million equity investment loss versus a prior-year $926 million gain, leaving net earnings attributable to PMI down 6.9% and diluted EPS down 7.0% to $5.48. Third-quarter revenue grew 5.5% while Q3 net earnings fell 4.8%, indicating that non-operating and investment items, not core demand, are the primary drag. Cash generation improved sharply, with operating cash flow rising to $10,445 million from $7,524 million, and working-capital unwinds (finished product inventory down about 20% and accrued taxes down about 27% from year-end) partly explain the improvement, so the cash gain may not be fully repeatable. PepsiCo's Chairman and CEO sold 30,000 shares at $135.13 (about $4.05 million), a modest but notable insider sale that leaves him holding 491,645 shares. Walmart's $3.0 billion U.S. and C$5.0 billion Canadian senior notes priced at tight discounts to par, signaling strong, low-cost debt market access. Hormel's director retirement is administrative and immaterial. Across the group the dominant theme is revenue growth outpacing earnings growth, with non-operating charges and balance-sheet reshaping setting the market narrative.

3 high priority 1 medium 4 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 23, 2026

The 8 filings cover a single trading day (2026-10-23) and split into three clusters: American Express earnings and 10-Q disclosures showing strong headline growth (revenue +9% YoY to $20.1B, diluted EPS +31% to $5.42, FY26 EPS guidance raised to $18.30-$18.60) but uneven segment performance; a heavy run of Travelers Companies Form 4 insider sales and option exercises, led by Chairman/CEO Alan Schnitzer's roughly $83M tax withholding and $39.6M option exercise alongside multiple EVP sales near $405/share; and Walmart's $3.0B USD and C$5.0B CAD senior notes priced at near-par, closing October 23. Salesforce's Form 4 (Co-Founder Parker Harris tax withholding) is the only other in-scope item and is low-materiality. Portfolio-level, the notable pattern is clustered insider selling at Travelers near the $400+ price level, against a backdrop of AmEx credit-loss reserve releases that flattered the quarter, and a 18.1% effective tax rate that the company itself flagged may not recur. Strong credit-card and financing activity points to healthy consumer and corporate credit, but the quality of earnings beat needs scrutiny. Only one filing period is available, so true period-over-period trend synthesis is limited to the AmEx disclosures.

6 high priority 2 medium 8 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 23, 2026

The single filing in this stream, Las Vegas Sands' Q3 2026 10-Q, shows a business whose top line is growing on a nine-month basis while the latest quarter weakened, and whose capital structure has been reshaped by aggressive buybacks. Q3 net revenues fell 3.4% YoY to $3,216M from $3,331M, and net income attributable to LVS dropped 27.5% to $304M from $419M, while nine-month revenue still rose 6.3% to $9,955M. Nine-month net income was essentially flat (-1.2% to $1,217M from $1,232M), signalling that margin pressure is building into the most recent quarter. Casino revenue declined to $2,370M from $2,506M while casino operating expenses rose to $1,408M from $1,353M, a clear squeeze on operating leverage. Treasury stock purchases of $11,530M have pushed total stockholders' equity to a negative $(344)M, a balance-sheet signal that equity holders should weigh against shareholder-return intent. Credit-loss provisions nearly doubled over nine months to $86M from $39M, adding to the caution. Overall sentiment is mixed, and the materiality score of 8/10 reflects the significance of the buyback-driven equity position and the Q3 earnings deterioration for this sector.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 23, 2026

This digest covers a single Form 4-type insider transaction filing from Elevance Health, Inc. (an S&P 500 managed care/healthcare provider within scope). The only enriched event is a series of sales by EVP & CFO Kaye Mark totaling 2,343 shares at roughly $441 (~$1.03M), with 13 transactions reported and 19,919 shares retained afterward. Executed prices clustered between $434 and $441, with individual lots of 400, 321 and 1,660 shares. No period-over-period financial comparisons, guidance, capital allocation changes, M&A, or scheduled events were supplied in the enriched data, so portfolio-level trend analysis is not possible from this single filing. The filing's sentiment is classified negative with 7/10 materiality, which reflects the insider selling rather than any fundamental deterioration. Investors should treat this as a limited-information signal and look for the company's periodic financial filings and guidance to contextualize it.

1 high priority 1 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 22, 2026

Across the 21 filings in the USA S&P 500 Technology stream, the dominant theme is strong semiconductor-equipment and hardware momentum alongside a more mixed picture in legacy IT and software. Lam Research delivered record results with revenue of $8.22B (up 54% YoY per its 10-Q, 22% QoQ per its 8-K) and operating margin of 40.0%, but a 46% QoQ jump in tax expense trimmed net income growth relative to pre-tax growth. Texas Instruments posted revenue of $6.06B (up 28% YoY) and EPS up 77%, yet capital returns fell 11% YoY as buybacks dropped 61%, and its Q4 guidance band of $5.80B to $6.30B is wide. IBM showed steady top-line growth of about 5% with Software and Infrastructure leading, but IBM Z revenue fell 20% and Financing declined 4%, while $11.4B of acquisitions compressed free cash flow and cash fell about 32% YTD. Accenture filings are dominated by routine equity award vesting and tax withholding, with a cluster of Co-CEO and senior-officer share sales at roughly $240 to $250 that reads as normal liquidity rather than a clear conviction signal. Microsoft's proxy materials are governance-only, with 11 of 12 nominees independent and all four shareholder proposals recommended against. Overall, the stream reflects healthy earnings momentum in semiconductor capital equipment and semis, with cash deployment, tax normalization and legacy-segment erosion as the key watch items.

16 high priority 5 medium 21 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 22, 2026

Across the 12 filings, the NASDAQ-100 semiconductor and mega-cap platform names showed strong top-line momentum, while several media and advertising names showed contraction. Lam Research (revenue $8.22B, up 54% YoY, gross margin 52.3% vs 50.4%) and Texas Instruments (revenue $6.06B, up 28% YoY, net income up 78% YoY) led on growth and margin expansion, with Lam guiding December-quarter revenue to $8.60B. Meta and Comcast both showed headline earnings distorted by one-time items: Meta absorbed a $9.89B state attorneys general settlement charge (ex-charge diluted EPS would have been $7.40 vs reported $3.83) and Comcast's nine-month net income fell 48.7% against a prior-year $9.7B investment gain that did not recur. Tesla's flat revenue masked a 55.8% drop in operating income as R&D rose 69% to $2.76B, and its automotive regulatory credits fell 73%. Capital allocation diverged sharply: Meta repurchased no shares in nine months after $26.2B in the prior-year period while capex reached $83.1B, and Texas Instruments cut cash returns 11% YoY as buybacks fell 61%. Insider activity was limited to routine 10b5-1 sales at Apple and Starbucks and carried little signal. Overall, the cycle favors semiconductor equipment and analog/industrial silicon, while platform and media names are being hit by one-time charges, capex intensity and cost inflation.

7 high priority 5 medium 12 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 22, 2026

Five SEC filings dated October 22, 2026 were reviewed for the S&P 500 Financials stream. Four are in scope: Travelers Companies (three Form 4s), Citigroup (8-K board appointment), CME Group (Form 4), and AIG (13F-HR). The dominant theme is insider selling: Travelers executives sold roughly $8.4M of stock in aggregate, with the Chief Risk Officer and EVP Personal Insurance both monetizing positions near $393-398, while CME's director sold a small $121K block. The enriched data provided no period-over-period financial metrics, guidance, or capital allocation figures, so trend analysis is limited to insider and governance signals. AIG's 13F reveals a single 3.65M-share Rubrik position (~$175.6M per the filing, though the value field appears mis-scaled and should be verified). Citigroup's appointment of Jim Flanagan adds a former PwC COO/Vice Chairman with audit credentials to the board, a governance positive with no financial impact disclosed. Overall materiality is low; the most actionable item is the clustering of Travelers insider sales.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 22, 2026

Two S&P 500 Energy filings were published on 2026-10-22: Kinder Morgan's Q3 2026 8-K with substantive enriched results, and Valero's Q3 2026 8-K furnishing an earnings press release whose figures were not included in the provided content. Kinder Morgan delivered a strong quarter on headline metrics (net income attributable to KMI up 22% to $764 million, Adjusted EPS up 21% to $0.35, Adjusted EBITDA up 9% to $2.18 billion), with the expansion backlog growing to $14.4 billion, of which $13.2 billion is natural gas, supporting multi-year volume visibility. Performance was mixed underneath: Natural Gas Pipelines and Terminals grew, while crude and condensate volumes fell 11% YoY on lower Bakken flows and the Double H conversion to NGL service, and Products Pipelines earnings were absorbed by legal and environmental accruals classified as Certain Items. Leverage is a positive signal, with Net Debt-to-Adjusted EBITDA at 3.5x, the low end of the target range, and a year-end target of 3.6x versus a prior 3.8x budget, which points to balance-sheet headroom for the dividend (raised 2% YoY to $0.2975 per share) and project funding. Valero's filing carries no quantitative data and warrants a neutral read until the Exhibit 99.01 release is reviewed. Across the two names, the sector theme is gas-levered infrastructure strength offsetting pockets of crude-linked and litigation-related weakness.

2 medium 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 22, 2026

All three filings relate to Procter & Gamble (PG), so this digest is effectively a single-company read-through rather than a cross-company sector scan. Fiscal Q1 2027 (quarter ended September 30, 2026) delivered net sales of $23.3B, up 4.0% YoY, with organic growth also at 4.0% (2% volume, 1% mix), but earnings quality was weak: diluted EPS rose only 1% to $1.97, currency-neutral core EPS was flat, and net earnings attributable to P&G slipped 0.4%. Core gross margin contracted 150 bps on 140 bps of commodity cost inflation and 140 bps of reinvestment, partly offset by 120 bps of productivity savings. The balance sheet shifted toward short-term funding, with debt due within one year rising to $17.0B from $11.3B while cash rose to $15.4B from $9.9B, and interest expense grew 13.2%. Management raised all-in FY2027 sales growth guidance to 2-4% to reflect the Thorne acquisition while holding organic sales, EPS and cash return guidance, but flagged a ~$0.79/share headwind from commodities, interest, lower non-operating income and FX. The net read is mixed: top-line momentum is intact, but margin and FX pressure are absorbing the growth.

1 high priority 2 medium 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 22, 2026

Across the ten S&P 500 Industrials filings (Lockheed Martin, CSX, Honeywell, Union Pacific, Norfolk Southern and GE's 13F), the dominant theme is strong top-line momentum undermined by cost and cash-flow pressure. Revenue growth was broad: Lockheed sales rose 11.3% to $20.7B with a record $292.0B backlog, CSX revenue rose 12% to a record $4.02B, Union Pacific revenue rose 15.3% to $7.2B, and Norfolk Southern railway revenue rose 13.6% to $3.5B. However, margins and cash generation lagged. Union Pacific's fuel expense jumped 68.8% (costing roughly 140 bps of operating ratio), Norfolk Southern's adjusted operating ratio worsened 210 bps to 65.4% and eight of its 14 points of revenue growth came from fuel surcharges, and Lockheed's operating cash flow fell 8% with Aeronautics margin compressing to 9.0% from 9.4%. Honeywell's reported picture was distorted by a $6.6B deconsolidation gain and the Aerospace spin-off, with Q3 operating cash flow down 74% and an Industrial Automation segment down 23% on a reported basis. Rail carriers face a common fuel-cost headwind, and defense primes face a funding question on the F-35 Lot 20 advance contract. Capital return patterns diverged sharply: Lockheed and Union Pacific cut buybacks to near zero year-to-date, while dividends were steady.

5 high priority 5 medium 10 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 22, 2026

Across the 23 Dow Jones 30 filings (period 2026-10-22), the dominant theme is a split between strong top-line and cash-flow stories and weaker reported earnings quality. IBM (Q3 revenue +4.7% YoY to $17.1B, operating pre-tax margin +70 bps to 19.3%, but IBM Z -20% and Financing -4%) and Honeywell (organic +7% and adjusted EPS +34%, but reported EPS -20%, operating cash flow -74%, and Industrial Automation sales -23% reported) both show headline improvement masking underlying softness. Procter & Gamble delivered 4.0% sales growth but flat currency-neutral core EPS and a 150 bps core gross margin decline, while raising all-in FY2027 sales guidance to 2-4% on the Thorne acquisition. Honeywell's Q3 net income fell 64% YoY, and YTD results are dominated by a $6.6B deconsolidation gain and Aerospace Spin-Off accounting, so reported comparisons are not like-for-like. Insider activity is concentrated in Travelers (two EVP/CRO-level sales totaling roughly $8.4M, with sales by Klein and Olivo) and a single Apple SVP sale under a 10b5-1 plan, while Sherwin-Williams shows routine option grants across roughly 12 executives with no open-market buying. Capital allocation remains shareholder-friendly (IBM $1.69 quarterly dividend, P&G cash returns maintained), but IBM's $11.4B of acquisitions and P&G's shift to short-term debt ($17.0B due within one year, up from $11.3B) warrant balance-sheet monitoring. Governance filings for Microsoft (11 of 12 independent nominees, annual meeting December 8, 2026) are routine.

17 high priority 6 medium 23 total filings